Connecting to SEC EDGAR… PricingSign in
← All filings

ENGNW

enGene Therapeutics Inc. SEC filings
Biological Products, (No Diagnostic Substances) · Nasdaq, Nasdaq · Incorporated in Canada (Federal Level)
On the radar right now · 0
Nothing in the live feed for ENGNW right now.
Filing history
2026-09-24
Insider trade 4
Filing ↗
2026-09-08
Quarterly report 10-Q
Filing ↗
2026-09-08
Current report 8-K
Earnings results
Filing ↗
2026-08-14
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-08-14
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-08-14
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-08-13
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-08-12
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-08-11
Current report 8-K
Other event
Filing ↗
2026-07-22
New insider's holdings 3
Filing ↗
2026-07-22
New insider's holdings 3
Filing ↗
2026-07-22
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-07-17
Current report 8-K
Reg FD disclosure
Filing ↗
2026-07-16
Current report 8-K
Exec/director changeReg FD disclosure
Filing ↗
2026-06-18
Current report (amended) 8-K/A
Layoffs/restructuringExec/director change
Filing ↗
2026-06-17
Insider trade 4
Filing ↗
2026-06-17
Insider trade 4
Filing ↗
2026-06-17
Insider trade 4
Filing ↗
2026-06-17
Insider trade 4
Filing ↗
2026-06-17
Insider trade 4
Filing ↗
2026-06-17
Insider trade 4
Filing ↗
2026-06-17
Insider trade 4
Filing ↗
2026-06-17
Insider trade 4
Filing ↗
2026-06-15
Quarterly report 10-Q
Filing ↗
2026-06-15
Current report 8-K
Earnings resultsLayoffs/restructuringExec/director changeReg FD disclosureOther event
Filing ↗
2026-06-10
Current report 8-K
Shareholder vote
Filing ↗
2026-05-15
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-05-14
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-05-13
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-05-08
Annual report to shareholders ARS
Filing ↗
2026-05-08
Proxy statement (shareholder vote) DEF 14A
Filing ↗
2026-05-07
Current report 8-K
Exec/director changeReg FD disclosureOther event
Filing ↗
2026-05-05
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-04-09
Current report 8-K
Bylaws changeReg FD disclosure
Filing ↗
2026-03-09
Employee stock plan shares S-8
Filing ↗
2026-03-09
Prospectus 424B5
Filing ↗
2026-03-09
Current report 8-K
Material agreementAgreement ended
Filing ↗
2026-03-09
Quarterly report 10-Q
Filing ↗
2026-03-09
Current report 8-K
Earnings results
Filing ↗
2026-03-02
EFFECT EFFECT
Filing ↗